Skip to main navigation
Sophiris

Main navigation

  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Topsalysin
    • Prostate Cancer
    • BPH
  • Patients
    • Resources/Advocacy Groups
    • Clinical Trials
  • Publications
  • Investor
    • News
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Contact IR
  • News
  • Contact Us

Investor Relations

  • Overview
  • News
  • Events & Presentations
  • Corporate Governance
    • Corporate Governance Documents
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • Annual Meeting Materials
    • SEC Filings
    • Sedar Filings
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
    • Ownership Profile
  • Contact IR

Topsalysin Phase 3 Data from Positive Plus-1 Study as a Late Breaking Poster during the 111th American Urological Association Annual Meeting

May 7, 2016

Supporting Materials

View Presentation 794.6 KB

Shareholder Tools

  • Email Alerts
  • Printed Materials
  • RSS News Feeds
© Sophiris Bio Corp. 2017 All rights reserved
  • Terms and Conditions
@sophirisbio on Linkedin
MENU

Main navigation

  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Topsalysin
    • Prostate Cancer
    • BPH
  • Patients
    • Resources/Advocacy Groups
    • Clinical Trials
  • Publications
  • Investor
    • News
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Contact IR
  • News
  • Contact Us